Hepatic encephalopathy: Metabolic consequence of cirrhosis often is reversible

Postgraduate Medicine

Volumn 109, Issue 2, 2001, Pages 52-70

  Abou Assi, Souheil ^a,c   Vlahcevic, Z Reno ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AROMATIC AMINO ACID; BENZOIC ACID; BRANCHED CHAIN AMINO ACID; CARNITINE; FLUMAZENIL; KANAMYCIN; LACTITOL; LACTOSE; LACTULOSE; MANGANESE; METRONIDAZOLE; MONOAMINE; NEOMYCIN; OPIATE AGONIST; ORNITHINE ASPARTATE; PAROMOMYCIN; SEROTONIN AGONIST;

CLINICAL TRIAL; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PATHOGENESIS; PROTEIN RESTRICTION;

EID: 0035113807     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2001.02.850     Document Type: Conference Paper

References (20)

1. The neurobiology of hepatic encephalopathy
2. Portal-systemic encephalopathy: A disorder of neurone-astrocytic metabolic trafficking
3. Effect of acute ammonia intoxication on cerebral metabolism in rats with portocaval shunts
4. Synergism between mercaptans and ammonia or fatty acids in the production of coma: A possible role for mercaptans in the pathogenesis of hepatic coma
5. Ammonia and GABA-ergic neurotransmission: Interrelated factors in the pathogenesis of hepatic encephalopathy
6. Efficacy of Ro 151788 in cirrhotic patients with hepatic coma: Results of a randomized double blind placebo-controlled crossover trial
7. Pallidal hypersensitivity on magnetic resonance imaging in cirrhotic patients: Clinical correlations
8. Pallidal lesions in patients with liver cirrhosis: Clinical and MRI evaluations
9. Relationships between tryptophan in serum and CSF, and 5-hydroxyindolacetic acid in CSF of man: Effects of cirrhosis of the liver and probenecid administration
10. Increased activities of MAOA and MAOB in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy
11. Morphine imbalances in hepatic cirrhosis
12. Plasma methionine enkephalin concentrations and prognosis in primary biliary cirrhosis
13. The visual evoked potential in clinical hepatic encephalopathy in acute and chronic liver disease
14. Treatment of hepatic encephalopathy
15. Sodium benzoate in the treatment of acute hepatic encephalopathy: A double-blind randomized trial
16. Effect of L-carnitine upon ammonia tolerance test in cirrhotic patients
17. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy: A meta-analysis
18. Comparison of dietary proteins with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: A randomized control trial
19. Newer approaches to therapy of hepatic encephalopathy
20. Effect of vegetable and animal protein diets in chronic hepatic encephalopathy